PMID: 8965590Nov 23, 1996Paper

Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection

Lancet
H C ThomasJ A Summerfield

Abstract

Persistent with hepatitis B virus (HBV) affects 350 million people worldwide, and 20-40% of infected patients die of cirrhosis and liver cancer. Little is known about the host factors that determine the variable natural history. Studies have focused on the role of acquired rather than innate immunity. We have investigated the prevalence of mutations in the gene for mannose-binding protein (MBP), which have been associated with susceptibility to bacterial and fungal infections. Mutations in the MBP gene were sought by sequence-specific oligonucleotide hybridisation, site-directed sequencing in Caucasian and Asian patients with HBV infection, and in HBsAg-negative controls. A mutation in codon 52 of the MBP gene was present in two (11%) of 19 Caucasian patients with acute hepatitis B and nine (27%) of 33 Caucasian patients with chronic hepatitis B, compared with four (4%) of 98 Caucasian controls (p = 0.0004). By contrast the prevalence of the mutation was similar in Asian patients with chronic hepatitis B and in Asian controls (one [5%] of 20 vs two [2%] of 117). Mutations in codon 54 and codon 57 were found in similar proportions of patients and controls. These findings show in Caucasian, but not Asian, patients an association ...Continue Reading

References

Jun 29, 1991·Lancet·M SumiyaJ A Summerfield
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D R MilichA McLachlan
May 1, 1989·The Journal of Experimental Medicine·M KuhlmanR A Ezekowitz
Sep 15, 1989·The Biochemical Journal·M E TaylorJ A Summerfield
Apr 1, 1993·The Journal of Clinical Investigation·K L HartshornA I Tauber
Apr 20, 1995·The New England Journal of Medicine·M R ThurszA V Hill
Jul 1, 1993·The Biochemical Journal·R MalhotraR B Sim
Apr 1, 1993·The Journal of Steroid Biochemistry and Molecular Biology·U Gehring
Jan 1, 1996·European Journal of Human Genetics : EJHG·R J LipscombeM W Turner

❮ Previous
Next ❯

Citations

Nov 30, 2006·Cancer Immunology, Immunotherapy : CII·A St SwierzkoZ Sułowska
Jul 2, 2008·Journal of Clinical Immunology·Eirini KoutsounakiEmmanouil Galanakis
May 29, 2003·Human Immunology·Akito TsutsumiTakayuki Sumida
Sep 12, 2002·Biochimica Et Biophysica Acta·David C Kilpatrick
Apr 2, 1998·Current Opinion in Immunology·M MatsushitaT Fujita
Mar 11, 1999·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·D Babovic-VuksanovicR M Ten
Jul 20, 2002·Current Opinion in Pharmacology·Stephen Chanock, James G Taylor
Dec 11, 2002·Transfusion Medicine·D C Kilpatrick
Dec 11, 2002·Journal of Gastroenterology and Hepatology·Kwang-Hyub HanHye Young Chang
Mar 25, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C L ThioM Carrington
Dec 11, 1997·The New England Journal of Medicine·W M Lee
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Y W TangD H Persing
Nov 14, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Damon P Eisen, Robyn M Minchinton
Mar 16, 2011·The Journal of Infectious Diseases·Ping AnUNKNOWN HBV Study Consortium
Dec 23, 1999·Current Opinion in Hematology·C B Foster, S J Chanock
Nov 30, 2006·Critical Care Medicine·Michelle N GongDavid C Christiani
Jan 1, 1997·Journal of Viral Hepatitis·H C Thomas, M R Thursz
Jan 29, 2008·Journal of Viral Hepatitis·L SegatS Crovella
Oct 6, 2000·APMIS. Supplementum·U L Holmskov
Jul 5, 2005·Journal of Virology·Chloe L ThioDavid L Thomas
Nov 10, 2001·Annual Review of Genomics and Human Genetics·A V Hill
May 23, 1998·Annual Review of Immunology·A V Hill
Aug 17, 1999·The Journal of Clinical Investigation·S J Chanock, C B Foster
May 3, 2008·BMC Infectious Diseases·Elizabeth E BrownThomas R O'Brien
Sep 23, 2008·World Journal of Gastroenterology : WJG·Zhi-Tao YangZhi-Meng Lu
Aug 31, 2000·Biochemical and Biophysical Research Communications·S JüligerJ F Kun
Jul 10, 2012·European Journal of Gastroenterology & Hepatology·Virginia ChatzidakiEmmanouil Galanakis
Jan 16, 2009·Cancer Letters·Wei SunFuchu He
Oct 19, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Wai Po ChongYu Lung Lau
Sep 16, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Guohong DengFuchu He
Apr 17, 2004·Clinical and Experimental Immunology·M CedzynskiD C Kilpatrick
Feb 16, 2006·Scandinavian Journal of Immunology·L Bak-RomaniszynI Płaneta-Małecka

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.